Helen Rubenstein
Vice President, Investor Relations and Communications
Replay available
Neumora Therapeutics, Inc. (NASDAQ: NMRA) Q1 2025 earnings conference call, held 2025-05-12. Replay captured from the company's public earnings webcast.

Vice President, Investor Relations and Communications
Chief Executive Officer
President
Chief Operating and Development Officer
Chief Financial Officer
Analyst, HC Wainwright & Co.
Analyst, Guggenheim
Analyst, Mizuho Securities
Watch the replay and follow the connected company analysis, news, and investor updates for Neumora Therapeutics, Inc..
WEBVTT 00:00:00.031 -- 00:00:01.853 Ladies and gentlemen, thank you for standing by. 00:00:01.853 -- 00:00:05.876 At this time, all participants are in a listen-only mode. 00:00:05.876 -- 00:00:09.740 After the speaker's presentation, there will be a question and answer session. 00:00:09.740 -- 00:00:13.583 Please be advised that today's conference is being recorded. 00:00:13.583 -- 00:00:17.447 I would now like to turn the conference over to Helen Rubenstein, Vice President of Investor 00:00:17.447 -- 00:00:21.270 Relations and Communications. Please go ahead. 00:00:21.270 -- 00:00:26.615 Good afternoon, and thank you for joining Numora Therapeutics' first quarter 2025 financial 00:00:26.615 -- 00:00:31.715 results conference call. Before we begin, I encourage everyone to go to the Investors 00:00:31.715 -- 00:00:35.817 and Media section of our website at numoratx.com, 00:00:35.939 -- 00:00:39.322 where you can find the press release related to today's call. 00:00:39.322 -- 00:00:45.528 With me from Numora are Chief Executive Officer Paul Burns, President Josh Pinto, 00:00:45.528 -- 00:00:50.293 Chief Operating and Development Officer Bill Arora, and Chief Financial Officer Mike 00:00:50.293 -- 00:00:51.814 Milligan. 00:00:51.814 -- 00:00:55.938 I'd like to point out that we will be making forward-looking statements, which are based 00:00:55.938 -- 00:01:00.702 on our current expectations and beliefs. These statements are subject to certain risks 00:01:00.702 -- 00:01:04.986 and uncertainties, and our actual results may differ materially. 00:01:04.986 -- 00:01:09.831 Please review the risk factors discussed in today's press release and in our SEC filings 00:01:09.831 -- 00:01:15.256 for additional detail. With that, I'll now turn the call over to Paul. 00:01:15.256 ...